Risk of Second Malignancies and T-Cell Lymphoma After CAR T-Cell Therapy | VuMedi

Stanford Medicine

Risk of Second Malignancies and T-Cell Lymphoma After CAR T-Cell Therapy

By Stanford Medicine FEATURING Mark Hamilton

By Stanford Medicine FEATURING Mark Hamilton

0 views

June 28, 2024

Comments 0

Login to view comments. Click here to Login